Number of Shares
83,895.00
Current Holdings Value*
$6.80 Mil
% of Portfolio
6.18%
Total Estimate Gain
$-2.44 Mil
% of Total Estimate Gain
-12.61%

CHIRON CAPITAL MANAGEMENT, LLC's SPDR Biotech ETF Holding Summary

As of 2025-03-31, CHIRON CAPITAL MANAGEMENT, LLC held 83,895.00 shares of SPDR Biotech ETF(XBI), totaling $6.80 Mil. This investment constitutes 6.18% of their stock portfolio, and CHIRON CAPITAL MANAGEMENT, LLC now holds 0.13% of the outstanding SPDR Biotech ETF(XBI) stock.

The initial trade took place in 2020Q3. And since then CHIRON CAPITAL MANAGEMENT, LLC has made 8 purchases of XBI, at an average price of $98.32, for a total of 196,885.00 shares. In addition, there have been 10 sales at an average price of $88.09 for 112,990.00 shares. Based on historical transaction data and XBI's current price of $83.01, CHIRON CAPITAL MANAGEMENT, LLC's estimated gain on his XBI holdings is $-2.44 Mil, reflecting a -12.61% gain to date.

CHIRON CAPITAL MANAGEMENT, LLC XBI ($83.01) Holding Chart

CHIRON CAPITAL MANAGEMENT, LLC XBI ($83.01) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1